House Patent Reform Bill: Battle Looms Over Patent Reexamination Provisions
This article was originally published in The Gray Sheet
Executive Summary
The six-year battle over patent reform legislation is not yet over as the device and drug industries and other leading industry stakeholders are unhappy with provisions in the House bill that differ from the recently passed Senate measure.